APAC/LATAM Regulatory Affairs Hematology Lead (Senior Director)

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Main Responsibilities and Accountabilities:

• The position holder is accountable for driving and implementing Innovative Regional Regulatory TA Strategies for the APAC/ LATAM TA.
• Driving and executing comprehensive, commercially and globally aligned regional regulatory activities across APAC/ LATAM Region for the TA.
• Accountable for CSL relationship with HA in the Region.
• Drive empowerment and capability-building initiatives for the TA team of RRL’s, fostering informed decision-making and strong regional ownership.
• Establish and enhance effective communication channels and knowledge-sharing frameworks across local and global stakeholders.
• Represent Global Regulatory in regional or global health authority inspections and strategic meeting

Qualifications & Experience Requirements

• Advanced degree in Life Science or Business with a post graduate qualification (PhD, MD, MBA or other).
• 15+ years' experience in the pharmaceutical industry, at least 10 years' experience in Global Regulatory Affairs; biologics regulatory experience preferred.
• 10+ years' leadership experience, including managing global regulatory teams.
• Different qualifications or responsibilities may apply based on local legal and/or educational requirements.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .

Our Benefits